| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.218 | 91.972 | 58.006 | 83.987 | 86.493 | 84.106 | 83.964 | 85.554 | 99.434 | 102.992 |
| Total Income - EUR | 66.262 | 100.677 | 64.342 | 88.730 | 90.258 | 91.699 | 86.887 | 91.326 | 102.986 | 103.797 |
| Total Expenses - EUR | 54.185 | 73.316 | 56.089 | 53.106 | 57.657 | 55.764 | 40.641 | 60.565 | 71.034 | 54.844 |
| Gross Profit/Loss - EUR | 12.077 | 27.361 | 8.253 | 35.624 | 32.601 | 35.935 | 46.246 | 30.761 | 31.952 | 48.953 |
| Net Profit/Loss - EUR | 10.233 | 24.602 | 6.513 | 33.070 | 30.131 | 35.140 | 45.396 | 29.905 | 30.955 | 46.863 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Solaris Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 279.184 | 258.510 | 249.832 | 244.780 | 222.586 | 149.116 | 151.146 | 227.819 | 209.500 | 189.546 |
| Current Assets | 96.285 | 58.933 | 58.160 | 107.430 | 133.357 | 144.163 | 71.186 | 125.261 | 72.109 | 41.948 |
| Inventories | 0 | 0 | 0 | 340 | 0 | 0 | 0 | 0 | 1.173 | 0 |
| Receivables | 6.272 | 29.306 | 3.499 | 1.768 | 26.392 | 9.794 | 39.390 | 46.763 | 13.079 | 13.484 |
| Cash | 90.012 | 29.627 | 54.661 | 105.323 | 106.964 | 134.369 | 31.796 | 78.498 | 57.857 | 28.465 |
| Shareholders Funds | 385.277 | 141.038 | 120.979 | 151.829 | 140.321 | 143.240 | 151.099 | 135.936 | 136.665 | 151.982 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 21.145 | 223.312 | 225.229 | 223.912 | 224.900 | 167.404 | 91.976 | 235.205 | 145.683 | 80.318 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Solaris Med S.r.l.